66.08

1.57% 1.02

After Hours: 65.88 -0.20 -0.30%

Disc Medicine Inc (IRON)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Disc Medicine Inc stock is traded at $66.08, with a volume of 375.74K. It is up +1.57% in the last 24 hours and up +10.79% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Previous Close:

$65.06

Open:

$65.07

24h Volume:

375.74K

Relative Volume:

1.08

Market Cap:

$2.30B

Revenue:

Net Income/Loss:

$-91.00M

P/E Ratio:

-18.01

EPS:

-3.67

Net Cash Flow:

$-74.38M

1W Performance:

+6.31%

1M Performance:

+10.79%

6M Performance:

+33.12%

1Y Performance:

+34.47%

1-Day Range:

$64.89

$66.58

1-Week Range:

$60.49

$68.43

52-Week Range:

$30.82

$68.73

Disc Medicine Inc Stock (IRON) Company Profile

Name

Disc Medicine Inc

Sector

Healthcare (1147)

Industry

Biotechnology (641)

Phone

(617) 674-9274

Address

321 ARSENAL STREET, SUITE 101, WATERTOWN

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

IRON's Discussions on Twitter

Compare IRON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRON Disc Medicine Inc	66.08	2.26B	0	-91.00M	-74.38M	-3.67
VRTX Vertex Pharmaceuticals Inc	391.64	101.35B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	456.00	58.66B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	562.27	59.43B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	737.56	44.01B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	340.70	36.56B	3.81B	-644.79M	-669.77M	-6.24

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-25	Initiated	Truist	Buy
Jul-03-25	Resumed	Morgan Stanley	Overweight
Jun-11-25	Resumed	Raymond James	Strong Buy
Feb-27-25	Initiated	TD Cowen	Buy
Nov-05-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-04-24	Upgrade	Raymond James	Outperform → Strong Buy
Oct-23-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy
Jun-07-23	Initiated	H.C. Wainwright	Buy
May-17-23	Initiated	Raymond James	Outperform
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight
Apr-21-23	Initiated	Stifel	Buy
Apr-20-23	Initiated	Morgan Stanley	Overweight
Mar-23-23	Initiated	BMO Capital Markets	Outperform
Feb-28-23	Initiated	SVB Securities	Outperform

View All

Disc Medicine Inc Stock (IRON) Latest News

Sep 30, 2025

Building trade automation scripts for Disc Medicine Inc.2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com

Sep 30, 2025

Disc Medicine Announces Submission Of NDA For Bitopertin - Nasdaq

Sep 30, 2025

Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria - MarketScreener

Sep 30, 2025

Disc Medicine submits NDA for bitopertin in erythropoietic porphyria - Investing.com

Sep 30, 2025

Disc Medicine Announces Submission of New Drug Application - GlobeNewswire

Sep 30, 2025

First Potential Treatment for EPP: Disc Medicine Files FDA Application for Breakthrough Drug Bitopertin - Stock Titan

Sep 30, 2025

Analyzing Disc Medicine Inc. with risk reward ratio chartsBuy Signal & Fast Exit/Entry Strategy Plans - newser.com

Sep 30, 2025

Will Disc Medicine Inc. stock recover after recent dropChart Signals & AI Optimized Trading Strategy Guides - newser.com

Sep 30, 2025

Developing predictive dashboards with Disc Medicine Inc. dataQuarterly Market Summary & High Return Stock Watch Alerts - newser.com

Sep 30, 2025

Sep 29, 2025

What momentum shifts mean for Disc Medicine Inc.Watch List & Weekly Breakout Stock Alerts - newser.com

Sep 29, 2025

Is Disc Medicine Inc. showing signs of accumulationPortfolio Update Summary & Real-Time Volume Analysis - newser.com

Sep 29, 2025

Is a relief rally coming for Disc Medicine Inc. holdersWeekly Stock Summary & Community Consensus Stock Picks - newser.com

Sep 29, 2025

Is Disc Medicine Inc. stock cheap at current valuationEarnings Overview Summary & Accurate Buy Signal Notifications - newser.com

Sep 29, 2025

Should you wait for a breakout in Disc Medicine Inc.Quarterly Investment Review & Safe Entry Trade Reports - newser.com

Sep 29, 2025

Identifying reversal signals in Disc Medicine Inc.2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com

Sep 29, 2025

Quantitative breakdown of Disc Medicine Inc. recent moveShare Buyback & Free Weekly Watchlist of Top Performers - newser.com

Sep 29, 2025

Sep 28, 2025

What drives Disc Medicine Inc stock priceEarnings Per Share Trends & Minimal Investment Big Returns - earlytimes.in

Sep 28, 2025

Sep 26, 2025

Is Disc Medicine Inc a good long term investmentTop Performing Stocks & Amplify Gains With Picks - Early Times

Sep 26, 2025

Sep 24, 2025

7,000 Shares in Disc Medicine, Inc. $IRON Acquired by Strs Ohio - MarketBeat

Sep 24, 2025

Sep 23, 2025

Atle Fund Management AB Makes New $1.31 Million Investment in Disc Medicine, Inc. $IRON - MarketBeat

Sep 23, 2025

Sep 22, 2025

Using AI based signals to follow Disc Medicine Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - newser.com

Sep 22, 2025

Sep 21, 2025

Risk vs reward if holding onto Disc Medicine Inc.M&A Rumor & Low Risk Entry Point Tips - newser.com

Sep 21, 2025

Sep 19, 2025

Aug Movers: Is Disc Medicine Inc stock technically oversoldBond Market & AI Optimized Trade Strategies - khodrobank.com

Sep 19, 2025